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Recently, numerous rare de novo mutations have been identified in patients diagnosed with
autism spectrum disorders (ASD). However, despite the predicted loss-of-function nature of
some of these de novo mutations, the affected individuals are heterozygous carriers, which
would suggest that most of these candidate genes are haploinsufficient and/or lead to
expression of dominant-negative forms of the protein. Here, we tested this hypothesis with
the candidate ASD gene Nuak1 that we previously identified for its role in the development of
cortical connectivity. We report that Nuak1 is haploinsufficient in mice with regard to its
function in cortical development. Furthermore Nuak1+/− mice show a combination of
abnormal behavioral traits ranging from defective spatial memory consolidation, defects in
social novelty (but not social preference) and abnormal sensorimotor gating. Overall, our
results demonstrate that Nuak1 haploinsufficiency leads to defects in the development of
cortical connectivity and a complex array of behavorial deficits.
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Neurodevelopmental disorders form a group of disabilitiesresulting from impairment of brain development andinclude syndromes such as Autism Spectrum Disorders
(ASD), intellectual disability, Attention Deficit/Hyperactivity
Disorder (AD/HD), and schizophrenia. The etiology of neuro-
developmental disorders is complex as it involves a marked
genetic contribution but probably also some environmental fac-
tors and/or a complex interaction between genes and environ-
ment1–4. Despite strong heritability, less than 10% of syndromes
such as ASD can be attributed to dominant mutations in a single
gene1. Recent studies revealed a large array of rare, de novo
mutations in ASD patients5,6. Yet their biological significance
remains elusive largely because, despite the predicted loss-of-
function nature of some of these de novo mutations, the affected
individuals are heterozygous carriers, suggesting that most of
these candidate genes are either haploinsufficient and/or that
these mutations lead to expression of dominant-interfering forms.
The cellular and molecular mechanisms underlying the estab-
lishment of neuronal connectivity have been extensively studied.
Extracellular factors such as axon guidance cues, neurotrophins,
and other growth factors convey information provided by the
local environment that is relayed to intracellular signaling
molecules to coordinate axon morphogenesis through the trig-
gering of local cellular processes7. One such signaling relay, the
serine/threonine kinase LKB1, is involved in several aspects of
axonal development in the mouse cortex. Lkb1 is a tumor sup-
pressor gene encoding a “master kinase” that activates a group of
14 downstream effectors forming a specific branch of the kinome
and related to the metabolic regulator AMPK8,9. LKB1 exerts
sequential functions in neuronal development through the acti-
vation of at least two distinct sets of AMPK-related kinases
(AMPK-RK): neuronal polarization and axon specification
through the kinases BRSK1/2 (SAD-A/B)10–12, and axon elon-
gation and branching through NUAK1 (ARK5/OMPHK1)13.
Furthermore the BRSK ortholog SAD-1 is involved in synapse
formation in C. elegans14,15, whereas in the mouse cortex LKB1
has been shown to regulate synaptic transmission and neuro-
transmitter release through its ability to control presynaptic
mitochondrial Ca2+ uptake16.
Several genes belonging to the AMPK-RK family came out of
recent unbiased genetic screens for rare de novo mutations
associated with neurodevelopmental disorders (Supplementary
Table 1)17–19. Yet the functional consequences of these mutations
and to what extent they contribute to the physiopathology of the
disease remain unknown. To address this question, we focused on
Nuak1, one of the AMPK-RK genes strongly expressed in the
developing brain13,20. Mutations in the Nuak1 gene have been
linked to ASD17,21, cognitive impairment19, or AD/HD22. Inter-
estingly the patients carrying these rare de novo mutations are
heterozygous carriers. Therefore, the actual contribution of these
mutations to the disease mechanisms suggests that Nuak1 must
be either haploinsufficient and/or the mutated allele must be
exerting a dominant-negative influence over the wild-type allele.
In this study, we present evidence demonstrating that the
inactivation of one allele of the Nuak1 gene results in a complex
phenotype including growth retardation, defective axonal mito-
chondria trafficking, and decreased terminal axon branching of
cortico-cortical projections. We reveal that Nuak1 heterozygosity
leads to disruption of several cognitive processes, alters the pre-
ference for social novelty without affecting conspecific social
preference, and decreases the prepulse inhibition (PPI) of the
acoustic startle reflex. Finally, using a gene-replacement strategy
we characterized the functional consequence of Nuak1 rare de
novo mutation identified in ASD patients.
Overall, our results indicate that Nuak1 is haploinsufficient
regarding its role in the development of cortical connectivity and
support the hypothesis that loss-of-function mutations in Nuak1
participates in the etiology of neurodevelopmental disorders.
Results
NUAK1 haploinsufficiency impairs mouse cortical develop-
ment. Using in situ hybridization, we found that Nuak1 mRNA is
highly expressed in the developing and adult mouse brain, with
specific expression pattern in the developing and adult neocortex,
pyriform cortex, hippocampus, and cerebellum. In contrast,
Nuak1 expression was low or absent in the dorsal thalamus and
striatum (Supplementary Fig. 1A-I). Western-blot analyses from
mouse brain extracts confirmed that NUAK1 protein is expressed
at high level in the developing and adult cortex. In the hippo-
campus, NUAK1 expression was maintained throughout all
developmental stages, although it decreased with age (Supple-
mentary Fig. 1J).
In mice, constitutive knockout (KO) of Nuak1 is lethal in the
late embryonic/perinatal period due to an abdominal midline
closure defect called omphalocoele20. Despite strong expression
in the embryonic brain, the initial characterization of Nuak1 KO
embryos did not reveal any obvious morphological brain defect20.
Accordingly, we did not observe any difference between wild type
(WT), heterozygous (HET), and KO embryos in axonal markers
(SMI312) or cortical lamination (TBR1: layer 6, and CTIP2: layer
5), indicating no major abnormalities in neuronal polarization,
axon tract formation, neurogenesis, neuronal migration, and
lamination (Supplementary Fig. 2A-F). NUAK1 protein level was
markedly decreased (~50%) in HET neurons (Fig. 1a), suggesting
that the remaining allele does not compensate for the loss of one
copy of Nuak1. We observed no change in the expression of
several members of the AMPK family including NUAK2, AMPK,
and BRSK2 (SAD-A) and a moderate increase in BRSK1 (SAD-B)
expression resulting from the decrease of NUAK1 expression
(Supplementary Fig. 2M), suggesting limited compensation of
Nuak1 loss by other AMPK-like family members, matching our
previous observations13 that NUAK1 exerts a specific function in
developing cortical neurons.
Unlike homozygotes constitutive knockout (NUAK1−/−),
heterozygous mice (NUAK1+/−) are viable and fertile and
do not display the omphalocoele phenotype. Quantitative analysis
revealed a moderate but significant growth retardation in
NUAK1+/− compared to WT littermates (Fig. 1b, c), a phenotype
more pronounced in males than females. We performed
histochemical analyses of NUAK1+/− mouse brains at Postnatal
day (P)21 (weaning) (Fig. 1d–e) or P40 (young adult) (Supple-
mentary Fig. 2G-L). The global organization of the brain appeared
largely normal, with no significant difference in cortical lamina-
tion (Supplementary Fig. 2I-L) between WT and HET animals. At
the cellular level, neuronal differentiation also seemed unaffected
with normal segregation of somatodendritic and axonal markers
(Supplementary Fig. 2G-H). Yet the most striking observation was
a marked enlargement of the lateral ventricles in NUAK1+/− mice
never observed in WT littermates on this C57Bl/6 J genetic
background (Fig. 1d–e and Supplementary Fig. 2g–h). The size of
lateral ventricles was nearly doubled in NUAK1+/− mice (Fig. 1f),
which was accompanied by a corresponding thinning of the cortex
along its radial axis (Fig. 1g), whereas the volume of two other
telencephalic brain structures (the striatum and hippocampus)
was not affected (Fig. 1h–i). Overall, our data suggest that
although NUAK1+/− mice are viable, Nuak1 is haploinsufficient
with regards to its function during brain development.
Dose-dependent role of NUAK1 in cortical axon development.
We previously characterized that NUAK1 is necessary and suf-
ficient for terminal axon branching of layer 2/3 cortical neurons
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through its ability to regulate the presynaptic capture of mito-
chondria13. In order to determine if these phenotypes are also
observed upon loss of one copy of Nuak1, we first performed
neuronal cultures following ex utero cortical electroporation
(EUCE) of WT, NUAK1+/−, and NUAK1−/− embryos at E15.5.
We observed a significant reduction of axon length and branching
in NUAK1+/− and NUAK1−/− neurons when compared to WT
neurons (Fig. 2a–c). The fraction of stationary mitochondria in
the axon was markedly decreased for both NUAK1+/− and
NUAK1−/− neurons compared to control WT neurons
(Fig. 2d–J). Quantifications confirmed that NUAK1 exerts a dose-
dependent effect on axon growth and branching and that HET
neurons display a significant reduction in both maximum axon
length and the number of collateral branches (Fig. 2g–i).
We subsequently turned to long-term in utero cortical
electroporation (IUCE) in order to label the axons of layer 2/3
Pyramidal neurons (PNs) in the primary somatosensory cortex
(S1) in WT (NUAK1+/+) and HET (NUAK1+/−) mice in vivo.
Mice were examined at Postnatal day (P)21, when terminal axon
branching of these cortico-cortical projecting (callosal) axons is
adult-like23,24. The loss of one copy of Nuak1 had no effect on
neurogenesis, radial migration, and axon formation (Fig. 2k–l).
Furthermore, callosal axons crossed the midline and reached the
contralateral hemisphere. However, we observed a marked
decrease in terminal axon branching on the contralateral
hemisphere in NUAK1+/− mice compared to WT littermates
(Fig. 2m, n). Interestingly, axon branching on the ipsilateral
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Fig. 1 Growth retardation and hydrocephaly in NUAK1 mutant mice. a Western-blot analysis of NUAK1 expression in 5DIV cortical neurons of WT, HET,
and KO animals. The star indicates a non-specific band. b Body size difference between males WT and HET NUAK1 mice at age P26. Scale bar 1 cm. c
Postnatal body weight growth curve of WT and HET NUAK1 mice before (P18), or after (P26-P40) weaning. Average ± SEM. NWT-females= 17, NHET-females
= 14, NWT-males= 14, and NHET-males= 8. Analysis: 2-way ANOVA with Bonferroni’s multiple comparisons. d, e Representative coronal sections of P21
NUAK1 WT (d) and HET (e) mice stained with Hoechst dye. f–i Measurement of ventricle size (f), cortex thickness (g), hippocampus (h), and striatum
size (i) from P21 coronal sections of NUAK1 WT and HET animals. Data represents min, max, median, 25th, and 75th percentile. Analysis: Two-tailed
unpaired T-test. (f, g, and i) NWT= 10, NHET= 15. h NWT= 7, NHET= 13. ns: p > 0.05, **p < 0.01, ***p < 0.001
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06584-5 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:4289 | DOI: 10.1038/s41467-018-06584-5 |www.nature.com/naturecommunications 3
observed in older mice (P90) mice (Supplementary Fig. 3),
indicating that this deficit in terminal axon branching does not
result from a simple delay in axon development and persists
through adulthood.
Alteration of the cognitive functions upon NUAK1 hetero-
zygosity. Despite being involved in cortical axon morphogenesis
(present study and ref.13), the functional consequences of Nuak1
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effect of Nuak1 haploinsufficiency on mouse behavior, we gen-
erated age-matched cohorts of WT and NUAK1+/− mice and
performed a battery of behavioral assays relevant to neurodeve-
lopmental disorders. Vision and olfaction were not impaired in
NUAK1+/− mice, as demonstrated by tracking of head move-
ment using an optomotor test (Supplementary Fig. 4A) and by
the habituation/dishabituation to novel odor test (Supplementary
Fig. 4B). Furthermore NUAK1+/− mice exhibited no difference
in spontaneous locomotor activity and exploratory behavior in
the Open Field (Supplementary Fig. 5A-C).
Next, we tested how NUAK1 heterozygosity affects memory
formation and consolidation through three distinct cognitive
paradigms: first, we investigated non-spatial memory using the
Novel Object Recognition (NOR) task25 (Fig. 3a). There were no
significant sex or genotype effects in the subsequent test trial;
however, both WT (p < 0.005) and NUAK1+/− (p < 0.01) mice
showed significant increase in number of object contacts (F
(1,35)= 14.21, p < 0.001) and contact times (F(1,35)= 15.63, p <
0.001), suggesting normal levels of interest for the novel objects in
both genotypes (Fig. 3b, c).
Second, we tested spatial memory formation and maintenance
using the Barnes Maze assay26 (Fig. 3c). While this test is similar
to the Morris Water Maze in probing spatial memory, it is less
physically taxing and does not induce stress/anxiety response
linked to swimming in water27. There were no significant
differences involving sex or genotype in the acquisition of escape
behavior. In the probe trial both WT and NUAK1+/− mice
showed a clear preference for the target quadrant relative to other
quadrants (Fig. 3d, probe test #1 [F(1,44)= 11.1, p < 0.005]).
However, when retested in the same conditions after one month
with the same platform location, while there was a significant
effect of quadrant exploration time (F(1,44)= 6.9, p < 0.01), only
WT mice showed a significant preference for the target quadrant
(p= 0.005), while NUAK1+/− mice did not (p= 0.45; Fig. 3e,
probe test #2).
Finally, we assessed associative learning and short-term
memory formation using the Fear Conditioning (FC) assay. On
day 1 of the test, adult NUAK1+/− and WT littermates were
placed in the experimental apparatus and their spontaneous
activity was recorded and automatically measured (Fig. 3g, day 1).
After a 2 min period, a neutral conditioned stimulus (30 s
auditory tone) was paired with a single aversive unconditioned
stimulus (mild electric foot shock). There was no difference in the
spontaneous activity of WT and NUAK1+/− mice during this
phase (Fig. 3g, day 1). On the second day, contextual and cued
fear conditioning was assessed over 3 minutes trials. We observed
a trend, albeit not significant, toward a reduction of the startle
response during the contextual phase of the assay both for the
total duration (p= 0.23; Fig. 3h, left) and number of startle events
(p= 0.67; Fig. 3h, right). On the contrary, NUAK1+/− mice had a
marked reduction of the cue-induced fear response both for total
duration (p= 0.012; Fig. 3h, left) and number of events recorded
(p= 0.039; Fig. 3i, right). Altogether, these results indicate that
NUAK1 partial loss-of-function disrupts short and long-term
memory processes in the mouse.
NUAK1 heterozygosity impairs novelty preference and sensory
gating. We next performed a series of behavioral assays relevant
to autistic-like traits. We observed spontaneous activity through
Open Field sessions (Supplementary Fig. 5A-F) but did not detect
any differences between WT and NUAK1+/− mice in behaviors
classically associated with anxiety or repetitive behavior. Since
these behaviors might be altered by the stress induced by the open
field environment, we repeated these observations in a home-cage
environment. Similarly, there was no genotype-dependent dif-
ference in spontaneous behaviors (grooming, scratching, or
rearing), although we observed a mild increase in spontaneous
activity and digging (Supplementary Fig. 5G-J).
Social interactions were assessed using the 3-chamber socia-
bility assay (Fig. 4a)28. There was no overall genotype difference,
but a significant overall effect of time in chamber (F(2,132)=
227.6, p < 0.0001) and direct contact times (F(1,66)= 51.3, p <
0.0001). NUAK1+/− mice displayed the same preference,
measured by the time spent in each chamber (Fig. 4b) and direct
object/mouse contact time (Fig. 4c) as their WT littermates when
offered a choice between another mouse and an inanimate object,
indicating that conspecific sociability is not affected by NUAK1
heterozygosity. In a second test, we assessed the preference of
NUAK1+/− mice for social novelty (Fig. 4d). In this case, there
were overall effects of chamber and contact times, but also
significant interactions between these factors and genotype (F’s –
3.7–5.1, p < 0.05). As expected, WT mice spent more time in the
chamber with the novel mouse and interacted more with the
novel individual. However, NUAK1+/− mice displayed no
preference between the familiar and the novel mouse (Fig. 4e,
f). Importantly, this effect was not due to a lack of interest for
novelty since NUAK1+/− mice showed a preference for a novel
object similar to their WT littermates in the NOR task (Fig. 3a–c).
Altogether, our results point to a deficit in the preference for
social novelty upon loss of one copy of Nuak1.
We subsequently investigated sensorimotor gating through
prepulse inhibition (PPI) of the startle response induced by
weaker prestimuli29,30 (Fig. 4g). We observed a marked
enhancement of the startle response in NUAK1+/− mice ([F
(1,44)= 24.9, p < 0.0001], Fig. 4h). Interestingly, there was a
significant interaction between startle sound level x genotype x
sex (F(7,308)= 2.09, p < 0.05), revealing a more pronounced
increase in NUAK1+/− males compared to NUAK1+/− females
(Supplementary Fig. 6B-C). This increased startle response was
accompanied by a significant reduction of PPI ([F(1,44)= 11.5,
p= 0.002], Fig. 4i), with stronger effect in males than in females
(Supplementary Fig. 6B-C). We retested the mice by submitting
NUAK1+/− to a milder tone in order to normalize the intensity
of the startle response between WT and NUAK1+/− animals.
Under these conditions, we observed a milder, and non-
significant PPI reduction in NUAK1+/− males and no difference
Fig. 2 NUAK1 is haploinsufficient for axon development. a–c Representative neurons imaged after 5DIV in WT, HET, and KO animals. Neuron morphology
was visualized through mVenus expression. Red star (*) points to branch position. d, f Representative kymographs of axons in WT, HET, and KO neurons
at 5DIV. Mitochondria were visualized through expression of mito-DsRed. Blue bar (vertical): 5 min. Blue bar (horizontal): 25 μm. g, i Quantifications
showed a gradual reduction in axon length (g) and collateral branches (h, i) in HET and KO animals. Data represents min, max, median, 25th, and 75th
percentile (g–i) or average ± SEM (j). NWT= 127, NHET= 232, NKO= 203. Analysis: one way ANOVA with Bonferroni’s post test. ns: p > 0.05, *p < 0.05,
**p < 0.01, ***p < 0.001. j Quantification of mitochondrial motility in the axon. Average ± SEM. NWT= 12, NHET= 9, NKO= 13. Analysis: Kruskal–Wallis test
with Dunn’s multiple comparison. k–n Higher magnification of the ipsilateral (k–l) or contralateral side (m–n) of P21 WT or HET mice following in utero
cortical electroporation of mVenus. Blue: Hoescht, Red: CUX1 immunostaining. Scale bar: 250 μm. o–p Quantification of normalized mVenus fluorescence
in Layer 5 of the ipsilateral cortex (min, max, median, 25th, and 75th percentile) (o) and along a radial axis in the contralateral cortex (Average ± SEM) (p).
NWT= 6, NHET= 5. Analysis: two-tailed unpaired T-test (o). ns: p > 0.05
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Fig. 3 Long-term memory consolidation phenotype of NUAK1 HET mice. a Novel object assay design. Mice were exposed to two similar objects, followed
by a change in one of the two objects. b, c Quantification of the number (b) and duration (c) of contacts during the novel object recognition assay. Average
± SEM. NWT= 19, NHET= 20. Analysis: 2-way ANOVA with Bonferroni’s multiple comparisons. **p < 0.01, ***p < 0.001. d Barnes Maze spatial memory
assay. e Quantification of time spent in target quadrant versus in other quadrants. f Mice were tested after 1 month to assess memory consolidation.
Average ± SEM. Analysis: 2-way ANOVA with Bonferroni’s multiple comparisons. ns: p > 0.05, *p < 0.05, ***p < 0.001. g, i Fear conditioning assay. g On
day 1, mice were placed in the apparatus for 3 min. After a 2 min period, a 30 s tone was produced, and paired with a single electric shock. Spontaneous
activity was recorded over 30 s bins. h–i on day 2, mice were tested for startle response (total duration and number of events) upon exposition to the same
environment (contextual memory) and upon exposure to the tone in a modified environment (cued memory). Average ± SEM. NWT= 4, NHET= 7.
Analysis: Mann–Whitney (h) or 2-way ANOVA with Bonferroni’s multiple comparisons (i). ns: p > 0.05, *p < 0.05
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in NUAK1+/− females compared to control WT littermates
(Supplementary Fig. 6D-E, see figure legend for statistical results).
Finally, the optimal InterStimulus Interval (ISI) was similar
between WT and NUAK1+/− mice, and the PPI was impaired at
all ISI examined, indicating that the deficit in PPI does not result
from an abnormality in the temporal function of the startle reflex
(Supplementary Fig. 6A). Taken together, our results indicate that
NUAK1 heterozygosity induces a deficit in the PPI pointing to a
sensory gating defect most likely due to a strong increase in the
initial startle response.
NUAK1 cell-autonomously controls axon branching. Given the
embryonic lethality characterizing the NUAK1−/− constitutive
knockout, we generated a conditional floxed Nuak1 mouse model
(NUAK1F allele) (Supplementary Fig. 7A-B) in order to compare
partial and complete genetic loss of Nuak1 function during
development of cortical connectivity at postnatal stages. We first
performed primary cortical neuron cultures coupled with EUCE
of plasmids encoding Cre recombinase. The loss of one
(NUAK1F/+) or two (NUAK1F/F) allele of Nuak1 showed again a
dose-dependent effect on axon growth and branching (Supple-
mentary Fig. 7C-H), thus validating this new conditional
knockout as a potent loss-of-function allele phenocopying the
constitutive knockout.
Next, we performed long-term IUCE of plasmids encoding Cre




















































































































































Fig. 4 Sociability and sensorimotor phenotype of NUAK1 HET mice. a 3-chamber sociability assay design. b, c Quantification of time spent in each chamber
(b) and contact time with the mouse or the empty cage (c) did not reveal any social deficit in NUAK1 HET mice. Data: Average ± SEM. NWT= 36, NHET=
34. Analysis: 2-way ANOVA with Bonferroni’s multiple comparisons. ***p < 0.001. d Social novelty assay design. e, f Quantification of time spent in
chambers (e) and contact time with a familiar and a novel mouse (f). Data: Average ± SEM. NWT= 36, NHET= 34. Analysis: 2-way ANOVA with
Bonferroni’s multiple comparisons. ns: p > 0.05, *p < 0.05, ***p < 0.001. g Sensorimotor gating assay and measurement of the startle response. The startle
reflex intensity (h) and % inhibition of the startle response upon pre-stimulation with a milder tone (i) showed altered response in NUAK1 HET. Data
represents min, max, median, 25th, and 75th percentile (h) or average ± SEM (i). NWT= 24, NHET= 24. Analysis: 2-way ANOVA with Bonferroni’s multiple
comparisons. **p < 0.01, ***p < 0.001
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branching of layer 2/3 PNs in vivo at P21. Importantly, this
approach is also testing the cell-autonomy of NUAK1 deletion
since Cre-expressing neurons are relatively sparse (~10% of all
layer 2/3 neurons) and their axons grow in a largely wild-type
environment. Similarly to our observations in NUAK1+/− mice,
Nuak1 conditional deletion had no effect on neurogenesis, radial
migration, axon formation and ipsilateral branching (Figs. 5a–c
and 5G). However, we observed a marked decrease of
contralateral axon branching of layer 2/3 neurons upon
inactivation of one or both alleles (Figs. 5d–h), strongly arguing
that Nuak1 is haploinsufficient with regard to the establishment
of cortico-cortical connectivity during postnatal development.
In order to determine the consequence of a complete deletion
of NUAK1 on mouse behavior, we crossed NUAK1F/F mice with
NEXCRE mice31. The NEX promoter drives CRE expression
specifically in intermediate progenitors and in PNs of the dorsal
telencephalon, excluding GABAergic interneurons and astrocytes
or other non-neuronal cells. Conditional inactivation of one
(cHET) or both (cKO) copies of Nuak1 using NEXCRE had no
effect on mouse viability and postnatal growth (Fig. 6a and Sup-
plementary Fig. 8A). We then performed the NOR task and the
three-chambered social preference and social novelty assay on
age-matched cohorts of WT, cHET, and cKO animals. As was the
case upon constitutive deletion of NUAK1, there was no overall
effect of genotype on novel object recognition (Supplementary
Fig. 8B) and conspecific sociability as measured by time in
chamber (Fig. 6b) and direct contact times (Supplementary
Fig. 8C). However during the social novelty phase of the assay,
NUAK1 cHET and NUAK1 cKO mice showed a lack of
preference for the novel mouse compared to the familiar mouse
as measured by time in chamber (Fig. 6c) and direct contact
times (Supplementary Fig. 8D). Finally, we performed the FC
assay on NUAK1 cKO and WT littermate animals. As observed
in NUAK1+/− animals, there was no genotype-dependent
difference in the spontaneous activity during the training phase
of the assay (Fig. 6d) and no statistically different startle response
in the contextual FC (Fig. 6e, duration: p= 0.28, # startle: p=
0.39), however cued-FC was markedly reduced in NUAK1 cKO
animals (Fig. 6f, duration: p= 0.006, # startle: p= 0.001). Taken
together our results indicate that the complete inactivation of
Nuak1 in PNs of the dorsal telencephalon recapitulates the lack
of preference for social novelty and decreased cued fear
conditioning observed in NUAK1 HET mice, and thus confirms
that NUAK1 haploinsufficiency leads to defects in mouse social
behavior.
Functional analysis of a Nuak1 mutation associated with ASD.
Finally, we tested whether Nuak1 mutations identified in ASD
patients affect the function of the protein. The de novo mutation
most frequently identified in genetic studies and with the highest
confidence score is a nonsense mutation inducing a Premature
Termination Codon (PTC) corresponding to Glutamine 433 (mouse
434) of the protein (Fig. 7a and Supplementary Table 1). Notably
this PTC mutation occurs in the long, last coding exon of Nuak1
(Supplementary Fig. 7A) and thus is not predicted to be subjected to
nonsense-mediated decay32. The mutation (hereafter named
NUAK1 STOP) leads to the truncation of a large portion of the C-
terminal extremity (CTD) of the protein, and removes one activating
AKT-phosphorylation site as well as two GILK motifs required for
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Fig. 5 Cell autonomous reduction in axon branching of NUAK1-deficient neurons. a–f Histochemistry of the ipsilateral or contralateral side of NUAK1+/+,
NUAK1F/+, and NUAK1F/F mice at P21 following in utero electroporation with CRE and the fluorescent protein mVenus. Blue: Hoescht, Red: CUX1
immunostaining. Scale bar: 250 μm. g–h Quantification of normalized mVenus fluorescence in Layer 5 of the ipsilateral cortex (g) and along a radial axis in
the contralateral cortex (h). Data: Average ± SEM. NWT= 6, NHET= 13, NKO= 6. Analysis: Mann–Whitney test. ns: p > 0.05
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We used site-directed mutagenesis to introduce this PTC
mutation in NUAK1 coding plasmids, creating an expression
vector encoding NUAK1 STOP, and used this construct to
determine the consequences of NUAK1 protein truncation. We
observed by western-blot that the mutation had no impact on the
expression of the protein (Fig. 7b), suggesting that the removal of
a large portion of NUAK1 CTD is unlikely to reduce protein
stability. Importantly, the truncation did not affect the kinase
activity of the mutant protein (Fig. 7c).
We then investigated the consequences of expressing this
NUAK1 STOP protein on axon growth and branching. To reach
that goal, we adopted a gene-replacement strategy to express
either WT or mutant NUAK1 STOP protein in NUAK1-null
neurons and determined axon morphology at 5DIV. As reported
above upon conditional inactivation of NUAK1 expression
through Cre recombinase expression, neurons had shorter axons
with reduced branching (Fig. 7d–e). Re-expression of WT
NUAK1 protein fully rescued axon length and axon branching
(Fig. 7f). On the contrary two mutants, a kinase dead (KD)
mutant that totally abolishes NUAK1 catalytic activity, and a
mutant of the LKB1-activation site (TA), both failed to rescue the
axonal phenotypes (Fig. 7g–h) confirming that NUAK1 function
in axon morphogenesis is kinase-dependent. Interestingly,
NUAK1 STOP mutant could rescue axon elongation to the same
extent as the WT NUAK1, but was not able to rescue collateral
branch formation (Fig. 7i–n). Using a similar strategy, we
observed that NUAK1 STOP mutant failed to rescue mitochon-
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Fig. 6 Reduced preference for social novelty upon complete loss of NUAK1 in the cortex. a Breeding strategy for dorsal-telencephalon specific inactivation
of Nuak1. Observed proportion of each genotype was matching the expected proportion following mendelian rule. b, c 3-chamber sociability and social
novelty assay in NUAK1 cKO mice. Quantification of time spent in each chamber revealed a decreased preference for social novelty in cHET and cKO mice.
Data: Average ± SEM. NWT= 24, NcHET= 8, NcKO= 9. Analysis: 2-way ANOVA with Bonferroni’s multiple comparisons. ns: p > 0.05, ***p < 0.001. d–f
Contextual fear conditioning assay. d Automated measurement of spontaneous activity over 30 s bins during the tone-foot shock pairing. e, f Startle
response (total duration and number of events) upon testing of the contextual (e) and cued (f) fear conditioning. Average ± SEM. NWT= 5, NcKO= 4.
Analysis: Mann–Whitney (e) or 2-way ANOVA with Bonferroni’s multiple comparisons (f). ns: p > 0.05, **p < 0.01
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Fig. 7 Functional analysis of NUAK1 mutations through a protein-replacement strategy. a Structure of the NUAK1 protein (mouse) and predicted structure
of the Q434STOP mutant. Known or predicted domains are indicated. NTD: N-terminal domain. CTD: C-terminal domain. NES: Nuclear Export Sequence
(predicted). NLS: Nuclear Localization Sequence (predicted). b Validation of NUAK1 mutant expression in HEK293T cells by western-blot. c In vitro
measurement of kinase activity of wild type or mutant NUAK1. d–k Representative neurons imaged after 5DIV following ex vivo electroporation of the
indicated plasmids in NUAK1F/F animals. Neuron morphology was visualized through mVenus expression. Red stars (*) points to branch position. Scale bar:
100 μm. l–n Quantification of axon length (l), number of branches per axon (m) and normalized branch number (n) in neurons from (d–k). Quantifications
were normalized to the average value of Control (CTL) condition to allow comparison of distinct, independent experiments. Data represents min, max,
median, 25th, and 75th percentile. NCTL= 189, NCRE= 138, NCRE+WT= 90, NCRE+KD= 150, NCRE+TA= 174, NCRE+STOP= 125, NWT= 134, NSTOP= 198.
Analysis: Kruskal–Wallis test with Dunn’s multiple comparison. ns: p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001
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Fig. 9, quantified in Supplementary Fig. 9G). Thus the NUAK1
STOP mutant is a loss-of-function mutation that abolished its
function in mitochondria trafficking and axon branching.
We finally investigated whether the NUAK1 STOP mutation
acts as a dominant-negative when expressed in neurons
expressing endogenous WT NUAK1. We expressed either WT
or mutant forms of NUAK1 into WT neurons (NUAK1F/F
without Cre) by EUCE and observed axon morphology and
mitochondria trafficking at 5DIV. As observed previously13,
overexpression of WT NUAK1 was sufficient to increase axon
branching (Fig. 7j) and increase the pool of stationary
mitochondria in the axon (Supplementary Fig. 9C). In contrast,
neurons expressing the NUAK1 STOP mutant protein had
limited to no effect on axon length or branching (Fig. 7k) and
mitochondria trafficking (Supplementary Fig. 9E). Quantification
of axon morphology confirmed that NUAK1 STOP mutant failed
to increase branching (Fig. 7l–n). We only observed a moderate
reduction in collateral branch formation upon expression of the
NUAK1 STOP mutant. Furthermore, there was no effect of
NUAK1 STOP mutant expression on mitochondria trafficking in
wild-type neurons (Supplementary Fig. 9G). Altogether, expres-
sion of the NUAK1 STOP mutant had only a moderate inhibitory
activity over endogenous NUAK1 upon collateral branch
formation and no detectable inhibitory effect on axon elongation
and mitochondria trafficking, indicating that this mutant behaves
mostly as a loss-of-function mutant and phenocopies NUAK1
haploinsufficiency.
Discussion
In the present study, we characterized for the first time the
consequences of Nuak1 heterozygosity on brain development and
cortical circuit formation. Previous observations reported that
Nuak1 is highly enriched in the developing brain20,34, yet its
function in brain development was previously concealed by the
embryonic lethality of constitutive Nuak1 knockout mice. We
now report that Nuak1 expression remains elevated in the mouse
brain at various stages of postnatal development. Furthermore
our results demonstrate for the first time a dose-dependent effect
of NUAK1 on mitochondria trafficking, axon elongation and
branching.
The genetic architecture of neurodevelopmental disorders such
as ASD is emerging as complex and in the vast majority of cases
seems to deviate from mono-allelic, recessive mutations. Recent
evidence suggest that more often, rare de novo mutations are
found in ASD patients including potential loss-of-function
mutations in AMPK-RK such as Nuak117,19,21, Sik121, Brsk118,
or Brsk219. However, functional assessment of the phenotypic
impact of these rare de novo mutations is currently unknown.
Here we demonstrate for the first time that Nuak1 is hap-
loinsufficient with regard to brain development implying most
likely that heterozygote loss-of-function mutations in this gene
could cause defects in brain connectivity and a range of beha-
vioral defects compatible with ASD, intellectual disability, and
schizophrenia.
Many of the AMPK-RKs are enriched in the developing brain
and several have been linked to neurodevelopmental disorders.
For example, mutations in Sik1 have been identified in patients
suffering from developmental epilepsy35, and polymorphisms in
Mark1 are associated with an increased risk for ASD36. AMPK-
RKs might have partially overlapping functions: for example the
simultaneous inactivation of the polarity kinases BRSK1 (SAD-B)
and BRSK2 (SAD-A) is required to disrupt axon specification in
mouse cortical neurons yet Brsk1;Brsk2 double KO is lethal
shortly after birth12, whereas single gene inactivation is less
phenotypic and viable. We previously reported that NUAK1
function in axon branching is not shared by other AMPK-RKs
such as AMPK, BRSK1/2, or NUAK213. This lack of redundancy
between NUAK1 and other AMPK-RKs in axon branching might
explain why even heterozygous mutations in Nuak1 could have
important phenotypic consequences on brain development.
The main phenotype resulting from NUAK1 dosage reduction
is a decrease in terminal axon branching of cortico-cortical pro-
jections. Unlike Lkb1 deletion13, ipsilateral branching of
callosal axons was largely unaffected by the loss of Nuak1,
whereas contralateral branching was reduced upon loss of one
(NUAK1+/−) or two (NUAK1 cKO) copies of Nuak1. Ipsilateral
branching can be observed as early as P4 and is generated mostly
through interstitial branching37, contrary to the later terminal
contralateral branching. Hence a difference in the timing and/or
mechanism of branch formation might explain how ipsilateral
and contralateral branching might be differentially affected by
Nuak1 loss. Contralateral axon branching is significantly affected
by interfering with neuronal activity23,38. For example CUX1
inactivation results in an activity-dependent reduction in con-
tralateral, but not ipsilateral branching of layer 2/3 cortical PNs39.
Furthermore a disruption of neurotrophin-mediated signaling
(BDNF/TrkB) also results in a similar reduction of contralateral
axon branching40 while ipsilateral branching is largely unaffected.
Further studies will elucidate how the interplay between neuronal
activity and neurotrophin-mediated signaling may differentially
and locally regulate axon branching in a NUAK1-dependent way.
In this study, we adopted a gene-replacement strategy to
determine the functional relevance of one of the de novo muta-
tions in the Nuak1 gene potentially to ASD in human17 leading to
the expression of a truncated protein. Importantly, we confirmed
in cell lines that the mutant protein is stable, and that the
mutation does not abolish its catalytic activity in vitro (Fig. 7),
which likely explains how this mutant is able to partially rescue
the phenotype upon NUAK1 loss in neurons. Our data suggest
that the NUAK1 STOP mutation behaves as a loss-of-function
rather than a dominant-negative form of the protein since
NUAK1 STOP overexpression in WT cortical neurons did not
phenocopy NUAK1 loss-of-function. NUAK1 STOP over-
expression in WT cortical PNs had little impact on axon elon-
gation and mitochondria trafficking, and the reduction in axon
branching was not as pronounced as the reduction observed upon
CRE-mediated NUAK1 inactivation. Interestingly the NUAK1
protein has a long C-terminal tail containing potential regulatory
sites including an AKT phosphorylation site41 and three short
GILK motifs promoting NUAK1 interaction with Protein Phos-
phatase 1β (PP1β)33. LKB1 activation is achieved through nuclear
export and cytosolic capture within the STRAD/Mo25 com-
plex42,43. Similarly it is plausible that NUAK1 activity and sub-
cellular localization depend upon protein–protein interactions
through the C-terminal domain of the protein. Future investi-
gations will be needed to determine the molecular mechanisms
underlying the effects of this ASD-associated NUAK1 STOP
mutant.
The behavioral alterations in NUAK1+/− mice are largely
consistent with the identification of rare de novo Nuak1 muta-
tions in autistic patients17,21. NUAK1+/− mice display some
features associated with the autistic clinical spectrum, including
disruption of social novelty preference, moderate cognitive defi-
cits, and a reduction in the PPI reflecting a defect of sensory
gating. However, other behavioral alterations typical of ASD were
absent in NUAK1+/− mice. In particular, we did not detect ste-
reotyped or repetitive behavior in heterozygous mice, nor any
effect on general sociability. In humans, the large heterogeneity in
the clinical manifestations characterizing ASD patients partially
overlaps clinical manifestations associated with psychiatric dis-
orders such as schizophrenia44,45.
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Importantly most behavioral alterations we report here are
equally indicative of ASD, intellectual disability, and
schizophrenia-like pathology. Of note the overall activity of
NUAK1+/− mice was largely normal despite reports linking
Nuak1 mutations and AD/HD22. One important distinction
between ASD and schizophrenia is the age of the onset of phe-
notypes, schizophrenia being typically diagnosed at adolescence
or in young adults following a rather asymptomatic prodromal
phase, whereas autism is typically detected in young children. The
most commonly used behavioral tests relevant to ASD or schi-
zophrenia in the mouse are performed in young adults. Yet it is
worth noting that terminal axon branching defects can be
detected as early as P21 in NUAK1+/− mice, suggesting that
some phenotypic alterations might be present before or around
weaning. Future studies might address this question through the
measurement of ultrasonic vocalizations or measurement of
direct social interactions in juvenile animals. Importantly, we also
observed that the branching deficit persisted or even increased up
to stage P90, corresponding to the age when mouse behavior was
assessed.
Gene-network analyses of genes linked to ASD and other
neurodevelopmental disorders identified clusters of candidate
genes involved in synapse formation, protein synthesis and RNA
translation, signaling pathways, gene regulation, and chromatin
remodeling46–49. In line with that observation, a significant part
of the clinical manifestation can be reversed after the develop-
ment period, suggesting that synaptic plasticity plays an impor-
tant role in the disease50. Yet in parallel there is ample evidence
that ASD and schizophrenia have a strong developmental com-
ponent and that clinical manifestations may arise from early
insults to neural circuits formation. The main consequence of
NUAK1 heterozygosity is a reduction in axon branching of
cortico-cortical projections, suggesting a direct link between
axonal development and neurodevelopmental manifestations.
Interestingly a similar reduction in terminal axon branching has
been recently observed in a mouse model for the 22q11.2 dele-
tion, strongly associated to schizophrenia51. Our work strength-
ens the link between a disruption of cortical connectivity and
disruption in cognitive and social behavior in the mouse and
warrants further studies of axon development in the pathophy-
siology of neurodevelopmental disorders.
A recent study showed that NUAK1 mediates the phosphor-
ylation of the microtubule associated protein TAU on S356 and
might be involved in tauopathies such as Alzheimer’s disease
(Lasagna-Reeves et al., 2016). These results suggest that NUAK1
over-activation might lead to neurodegeneration. In the present
study, we have only examined the role of NUAK1 loss-of-
function during embryonic and early postnatal development, but
since its expression is maintained in the adult brain, future
experiments should address NUAK1 function in adult circuits
maintenance.
As a whole, we provide evidence that expression of the ASD-
associated Nuak1 Q433-Stop mutation disrupts cortical axon
branching in vivo. Coupled with our observation that Nuak1
heterozygosity impairs brain development, cortical axon
branching in vivo, and that NUAK1+/− mice have cognitive
and social novelty defects strongly argues that Nuak1 loss-of-
function mutations could be causally linked to neurodevelop-
mental disorders in humans and support targeted efforts to
identify additional genetic alterations in the Nuak1 gene. Future
experiments will need to determine if other rare de novo loss-
of-function mutations identified in genes such as Nuak1 are
also haploinsufficient with regard to development of brain
connectivity and if this is a general genetic mechanism
underlying a fraction of neurodevelopmental and/or neu-
ropsychiatric disorders.
Methods
Animals. Mice breeding and handling was performed according to protocols
approved by the Institutional Animal Care and Use Committee at The Scripps
Research Institute, Columbia University in New York, and the Ethics committee of
the University of Lyon, and in accordance with National Institutes of Health
guidelines and the French and European legislation. Time-pregnant females
were maintained in a 12 h light/dark cycle and obtained by overnight breeding
with males of the same strain. Noon following breeding was considered as E0.5.
NUAK1+/− mice (Nuak1tm1Sia) were obtained from the Riken Institute20. Floxed
NUAK1 mice were generated from targeted ES cells (Nuak1tm1a(KOMP)Wtsi)
obtained from the KOMP Repository from UC Davis (https://www.komp.org/
index.php, project ID CSD23401). Animals were maintained on a C57Bl/6 J
background.
Image acquisition and analyses. Confocal images were acquired in 1024 × 1024
mode with a Nikon Ti-E microscope equipped with the C2 (Supplementary Fig. 2
and Fig. 7) or the A1R (all others) laser scanning confocal microscope using the
Nikon software NIS-Elements (Nikon). We used the following objective lenses
(Nikon): ×10 PlanApo; NA 0.45, ×20 PlanApo VC; NA 0.75, ×60 Apo TIRF; NA
1.49. Time-lapse images were acquired in 512 × 512 mode with a Nikon Ti-E
microscope equipped with an EM-CCD Andor iXon3 897 Camera. Mitochondria
were imaged at 0.1 frames per second for 30 min. Analysis and tracking of confocal
and time-lapse images was performed with NIS-Elements software. Representative
neurons were isolated from the rest of the image using ImageJ. Contrast was
enhanced and background (autofluorescence of non transfected neurons in culture)
removed for better illustration of axons morphology. Kymographs were created
with NIS-Elements.
Behavior analyses. Two groups of age-related NUAK1 HET mice and WT lit-
termates were submitted to behavioral assays in the Mouse Behavioral Assessment
Core at The Scripps Research Institute in San Diego, CA. All quantifications were
performed by experienced technicians blind to genotype. Mice were between age 10
and 12 weeks at the start of testing. Procedure, quantification method, order of
experiments and group constitution is detailed in the Supplementary methods.
DNA, plasmids, and cloning. The empty vector pCAG-IRES-GFP (pCIG2), CRE-
expressing vector pCIG2-CRE52, mVENUS expressing vector pSCV253, and
mitochondria-tagged DsRed expressing pCAG-mitoDsRED13 were described pre-
viously. peGFP-Flag-mNUAK1 vector was created by amplifying mouse NUAK1
cDNA by PCR and cloning into a peGFP-C1 vector between XhoI and EcoRI sites.
A Flag-Tag was added at the N-terminal extremity of the protein by PCR. Kinase-
dead (K85A), phosphorylation-defective (T212A), and STOP (Q434STOP)
mutants were obtained by site-directed mutagenesis using the Quikchange II site-




Neuronal expressing vectors for NUAK1 (pCIG2-Flag-mNUAK1) were
obtained by inserting wild type and mutant NUAK1 cDNA into a pCIG2 vector
between XhoI and EcoRI sites.
Ex vivo cortical electroporation. For the electroporation of dorsal telencephalic
progenitors54, a mix containing 1 μg/μl endotoxin-free plasmid DNA (Midi-prep
kit from Macherey-Nagel) plus 0.5% Fast Green (Sigma; 1:20 ratio) was micro-
injected in lateral ventricles of the brain of E15.5 embryos using the MicroInject-
1000 (BTX) microinjector. Electroporations were performed on the whole head
(skin and skull intact) with gold-coated electrodes (GenePads 5 × 7 mm BTX) using
an ECM 830 electroporator (BTX) and the following parameters: Five 100 ms long
pulses separated by 100 ms long intervals at 20 V. Immediately after electropora-
tion, the brain was extracted and prepared as stated in the neuronal culture section
below.
Primary neuronal culture. Cortices from E15.5 mouse embryos were dissected in
Hank’s Buffered Salt Solution (HBSS) supplemented with Hepes (pH 7.4; 2.5 mM),
CaCl2 (1 mM, Sigma), MgSO4 (1 mM, Sigma), NaHCO3 (4 mM, Sigma), and D-
glucose (30 mM, Sigma), hereafter referred to as cHBSS. Cortices were dissociated
in cHBSS containing papain (Worthington) and DNAse I (100 μg/ml, Sigma) for
20 min at 37 °C, washed three times and manually triturated in cHBSS supple-
mented with DNAse. Cells were then plated at 12.5 × 104 cells per 35 mm glass
bottom dish (Matek) coated with poly-D-lysine (1 mg/ml, Sigma) and cultured for
5 days in Neurobasal medium supplemented with B27 (1×), N2 (1×), L-glutamine
(2 mM), and penicillin (5 units/ml)-streptomycin (50 mg/ml). To transfect cultured
neurons, we performed magnetofection using NeuroMag (OZ Bioscience)
according to the manufacturer’s protocol.
In utero cortical electroporation. Timed pregnant NUAK1+/− or NUAK1F/F
females were used for In utero cortical electroporation. A mix containing 1 μg/μl
endotoxin-free plasmid DNA (Midi-prep kit from Macherey-Nagel) plus 0.5% Fast
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Green (Sigma; 1:20 ratio) was injected into one lateral hemisphere of E15.5
embryos using a picospritzer. Electroporation was performed using an ECM 830
electroporator (BTX) with gold-coated electrodes (GenePads 3 × 5 mm BTX) to
target cortical progenitors by placing the anode (positively charged electrode) on
the side of DNA injection and the cathode on the other side of the head. Four
pulses of 45 V for 50 ms with 500 ms interval were used for electroporation.
Animals were sacrificed 21 or 90 days after birth by terminal perfusion of 4%
paraformaldehyde (PFA, Electron Microscopy Sciences) followed by 2 h post-
fixation in 4% PFA.
Western blotting. Cells and tissues were lysed in ice-cold lysis buffer containing
25 mM Tris (pH7.5), 2 mM MgCl2, 600 mM NaCl, 2 mM EDTA, 0.5% Nonidet P-
40, and 1 × protease and phosphatase mixture inhibitors (Roche). 20 μg aliquots of
lysate were separated by electrophoresis on a 10% SDS-polyacrylamide gel and
transferred on a polyvinylidene difluoride (PVDF) membrane (Amersham).
Incubation with primary antibody was performed overnight in 5% milk-TBS-
Tween. The next day, membranes were incubated at room temperature for 1 h with
HRP-linked secondary antibodies. Western-blot revelation was performed using
ECL (Amersham). Imaging and analysis were performed on a chemidoc imager
(Bio-rad) using the ImageQuant software. Images presented in the figures have
been cropped around the expected bands for figure design purpose. The original
(raw) data for Fig. 1a and Supplementary Figure 1J and including molecular weight
markers is presented in Supplementary Figure 10.
Statistical analyses. Sample size is detailed in the figures. Statistical tests were
performed using Prism (GraphPad Software). All statistical tests are two-tailed.
Normality test (D’Agostino & Pierson) was performed prior to analysis to dis-
criminate between parametric or non-parametric assay. Retrospective comparison
of variance was performed with a F-test.
Data availability
Supporting data of this study are available from the corresponding authors on
reasonable request.
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